Life Sciences
Cann Global Limited (ASX:CGB) presents its Quarterly report for the three months ended 30 September 2019.
The Board of Cann Global Limited (ASX:CGB) is pleased to announce that it is expanding the Company's current APAC/Asian presence and business activities, and has incorporated a further Asian focused subsidiary, Cann Global Asia Pty Ltd.
Cann Global Ltd (ASX:CGB) ("CGB" or "the Company") presents the annual report on activities for the year ending 30 June 2019.
The Board of Cann Global Limited (ASX:CGB) is pleased to provide an update on its recent exclusive distributorship supply contract deal signed with EPCO Foods Co. Ltd in Ho Chi Minh City, Vietnam.
The Board of Cann Global Limited (ASX:CGB) is pleased to announce that its T12 Food Division, under managers Sebastian and Samuel Edwards, have just signed an exclusive distributorship contract with EPCO Foods Co. Ltd in Ho Chi Minh City, Vietnam.
The Board of Cann Global Limited (ASX:CGB) is pleased to announce that its T12 Food Division, under managers Sebastian and Samuel Edwards, has become an official supplier to Costco.
Cann Global Limited (ASX:CGB) provides the following update in relation to CGB's Nutraceutical manufacturing schedule and the Israeli based Pharmocann formulator's visit to Australia.
The suspension of trading in the securities of Cann Global Limited (ASX:CGB) is expected to lift and the Company reinstated to official quotation at the commencement of trading on Friday 23 August 2019
Cann Global Limited (ASX:CGB) provides the following update in connection with the reinstatement to quotation of the Company's fully paid Ordinary Shares.
Cann Global Limited (ASX:CGB) provides the following update in connection with the reinstatement to quotation of the Company's fully paid Ordinary Shares.
Banking & Finance
- NSX Limited (ASX:NSX) Company Update
- ASIC vs iSignthis Ltd and Nickolas John Karantzis
- NSX Limited (ASX:NSX) Appointment of Managing Director and CEO - Max Cunningham